2. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43(11): 5721-5732.
4. Fabian TK, Fejerdy P, Csermely P. Saliva in health and disease. In: Begley TP (ed). Wiley Encyclopedia of Chemical Biology. Hoboken, NJ: John Wiley and Sons, Inc; 2008: 1-9.
5. Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Ann NY Acad Sci. 2007;1098:288-311.
6. Brodgen KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238-250.
7. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M. Candida albicans cell wall Ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem. 2006;281(32):22453-22463.
8. Fabian TK, Hermann P, Beck A, Fejerdy P, Fabian G. Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci. 2012;13(4):4295-4320.
10. Harp JR, Ellis E III, Tucker MR. Contemporary Oral and Maxillofacial Surgery. 7th ed. Philadelphia, PA: Elsevier; 2019.
11. Miliro M, Ghali GE, Larsen PE, Waite P. Peterson's Principles of Oral and Maxillofacial Surgery. 3rd ed. Shelton, CT: People's Medical Publishing House; 2012.
12. Dennis MJ. Treating odontogenic infections: an update for dental professionals. J Mich Dent Assoc. 2006;8(11):20-25.
13. Sequra-Eqea JJ, Martin-Gonzalez J, Jimenez-Sanchez MDC, Crespo-Gallardo I, Sauco-Marquez JJ, Velasco-Ortega E. Worldwide pattern of antibiotic prescription in endodontic infections. Int Dent J. 2017;67(4):197-205.
14. Munoz-Price LS, Jacoby GA. Extended-Spectrum Beta-Lactamases. Available at https://www.uptodate.com/contents/extended-spectrum-beta-lactamases. Last accessed May 15, 2023.
15. Drwaz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23(1):160-201.
16. Cotter G, Kavanagh K. Adherence mechanism of Candida albicans. Br J Biomed Sci. 2000;57(3):241-249.
18. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283(5407):1535-1538.
19. Raju SB, Rajappa S. Isolation and identification of Candida >from the oral cavity. ISRN Dent. 2011;2011:487921.
22. Cedeno-Mendoza R. Cytomegalovirus (CMV). Available at https://emedicine.medscape.com/article/215702-overview. Last accessed May 15, 2023.
23. Pellett PE, Roizman B. The family Herpesviridae: a brief introduction. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2013: 1802-1822.
24. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006:31(4):259-266.
25. Howley PM, Schiler JT, Lowy DR. Papillomaviruses. In: Knipe DM, Howley PM (eds). Fields Virology. 6th ed. Philadelphia: Lipincott, Williams and Wilkins; 2013: 1662-1703.
26. National Institutes of Health. Dental Caries (Tooth Decay). Available at https://www.nidcr.nih.gov/research/data-statistics/dental-caries. Last accessed May 15, 2023.
27. Piris-Lopez R, Aguilar L, Gimenez MJ. Management of odontogenic infections of pulpal and periodontal origin. Med Oral Patol Oral Cir Bucal. 2007;12(2):e154-e159.
28. Robertson D, Smith A.J. The microbiology of the acute dental abscess. J Med Microbiol. 2009;58(2):155-162.
29. Neville BW, Damm DD, Allen CM, Chi AC. Periodontal pathology. In: Neville BW, Damm DD, Allen CM, Chi AC (eds). Color Atlas of Oral and Maxillofacial Diseases. Philadelphia, PA: Elsevier; 2019: 93-107.
30. Jaramillo A, Arce RM, Herrera D, Betancourth M, Botero JE, Contreras A. Clinical and microbiological characterization of periodontal abscesses. J Clin Periodontol. 2005;32(12):1213-1218.
31. Herrera D, Roldan S, Gonzalez I, Sanz M. The periodontal abscess (I): clinical and microbiological findings. J Clin Periodontol. 2000;27(6):387-394.
32. Prato-Pini G, Magnani C, Rotundo R. Treatment of acute periodontal abscesses using the biofilm decontamination approach: a case report study. Int J Periodontics Restorative Dent. 2016;36(1):55-63.
33. Topazian RG, Goldberg MH, Hupp JR. Oral and Maxillofacial Infections. 4th ed. New York, NY: WB Saunders Company; 2002.
34. Centers for Disease Control and Prevention. HIV: Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications. Available at https://www.cdc.gov/hiv/statistics/surveillance/terms.html. Last accessed May 15, 2023.
36. Portela MB, Cerqueeira DF, Soares RMA, Castro GF. Candida spp. in linear gingival erythema lesions in HIV-infected children: reports of six cases. Int J Science Dentistry. 2012;1(37):51-55.
37. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1-6.
38. Todescan S, Nizar R. Managing patients with necrotizing ulcerative periodontitis. J Can Dent Assoc. 2013;79:d44.
39. Feller L, Lemmer J. Necrotizing gingivitis as it relates to HIV infection: a review of the literature. Perio Pract Today. 2005;2(1): 31-37.
40. Patton LL. The ADA Practical Guide to Patients with Medical Conditions. 2nd. Hoboken, NJ: Wiley & Sons, Inc.; 2016.
41. Laskin DM. Clinician's Handbook of Oral and Maxillofacial Surgery. 2nd ed. Hanover Park, IL: Quintessence Publishing Com Inc; 2019.
42. American Dental Association. ADA/PDR Guide to Dental Therapeutics. 5th ed. Montvale, NJ: Physicians' Desk Reference, Inc.; 2009.
43. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 25th ed. Hudson, OH: Lexicomp; 2019.
44. Chunduri NS, Madasu K, Goteci VR, Karpe T, Reddy H. Evaluation of bacterial spectrum or orofacial infections and their antibiotic susceptibility. Ann Maxillofac Surg. 2012;2(1):46-50.
45. Geddes AM, Klugman KP, Rolinson GN. Introduction: historical perspective and development of amoxicillin/clavulanate. Int J Antimicrob Agents. 2007;30(2):S109-S112.
46. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Carol Stream, IL: Quintessence Publishing Co, Inc.; 2001.
47. Little JW, Falace Donald L, Miller CS, Rhodus NL. Dental Management of the Medically Compromised Patient. 9th ed. St. Louis, MO: Mosby Elsevier; 2018.
48. eMedExpert. Azithromycin (Zithromax). Available at https://www.emedexpert.com/facts/azithromycin-facts.shtml. Last accessed May 15, 2023.
49. Edminister JR. Mucosal Candidiasis. Available at https://emedicine.medscape.com/article/1075227-overview. Last accessed May 15, 2023.
50. Reichart PA, Samaranayake LP and Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis. 2000;6:85-91.
51. Mukherjee PK, Chen H, Patton LL, et al. Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 infected participants. AIDS. 2017;31(1):81-88.
52. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.
53. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50(4):243-260.
54. Valdebran M. Noncandidal Fungal Infections of the Mouth. Available at https://emedicine.medscape.com/article/1077685-overview. Last accessed May 15, 2023.
55. Beyki A, Zardast M, Nasrollahi Z. Maxillary sinus aspergillosis: a case report of the timely failure to treatment. Iran J Microbiol. 2019;11(4):345-348.
56. MedlinePlus. Herpes – Oral. Available at https://medlineplus.gov/ency/article/000606.htm. Last accessed May 15, 2023.
57. Ayoade FO. Herpes Simplex. Available at https://emedicine.medscape.com/article/218580-overview#a4. Last accessed May 15, 2023.
58. Omori MS. Herpetic Whitlow. Available at https://emedicine.medscape.com/article/788056-overview. Last accessed May 15, 2023.
59. Kahn ZZ. Varicella-Zoster Virus (VZV). Available at https://emedicine.medscape.com/article/231927-overview. Last accessed May 15, 2023.
60. Centers for Disease Control and Prevention. Shingles (Herpes Zoster): Treating Shingles. Available at https://www.cdc.gov/shingles/about/treatment.html. Last accessed May 15, 2023.
61. Cade JE. Hairy Leukoplakia. Available at https://emedicine.medscape.com/article/279269-overview. Last accessed May 15, 2023.
63. Eversole LR. Papillary lesions of the oral cavity: relationship to human papillomaviruses. J Calif Dent Assoc. 2000;28(12):922-927.
64. Scully C, Epstein J, Porter S, Cox M. Viruses and chronic disorders involving the human oral mucosa. Oral Surg Oral Med Oral Pathol. 1991;72(5):537-544.
65. Ghadishah D. Genital Warts. Available at https://emedicine.medscape.com/article/763014-overview. Last accessed May 15, 2023.
66. Kellokoski J, Syrjanen S, Syrjanen K, Yliskoski M. Oral mucosal changes in women with genital HPV infection. J Oral Pathol Med. 1990;19(3):142-148.
67. Silverman S Jr. Color Atlas of Oral Manifestations of AIDS. 2nd ed. St. Louis, MO: Mosby, Inc.; 1996.
68. Eversole LR, Laipis PJ. Oral squamous papillomas: detection of HPV DNA by in situ hybridization. Oral Surg Oral Med Oral Pathol. 1988;65(5):545-550.
70. Ghalayani P, Tavakoli P, Eftekhari M, Haghighi MA. Oral focal epithelial hyperplasia: report of three cases. Turk Patoloji Derg. 2015;31(1):880-83.
71. Harris AM, van Wyk CW. Heck's disease (focal epithelial hyperplasia): a longitudinal study. Community Dent Oral Epidemiol. 1993;21(2):82-85.
72. Padayachee A, van Wyk CW. Human papillomavirus (HPV) DNA in focal epithelial hyperplasia by in situ hybridization. J Oral Pathol Med. 1991;20(5):210-214.
73. Dyall-Smith D. Focal Epithelial Hyperplasia. Available at https://www.dermnetnz.org/topics/focal-epithelial-hyperplasia. Last accessed May 15, 2023.
Mention of commercial products does not indicate endorsement.